Changes in Bone Turnover With Increased Incretin Hormone Exposure

NCT01374568 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Study closed by sponsor. Funding ended.

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: sitagliptin
OTHER: Placebo

Sponsor

University of Alabama at Birmingham